SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-227377
Filing Date
2017-07-13
Accepted
2017-07-13 11:19:02
Documents
5
Group Members
DMITRY GENKINLLC SYNBIO

Document Format Files

Seq Description Document Type Size
1 SC 13D d410062dsc13d.htm SC 13D 85560
2 EX-99.A d410062dex99a.htm EX-99.A 5190
3 EX-99.B d410062dex99b.htm EX-99.B 11042
4 EX-99.C d410062dex99c.htm EX-99.C 15863
5 GRAPHIC g4100621.jpg GRAPHIC 832
  Complete submission text file 0001193125-17-227377.txt   120676
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Subject) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89709 | Film No.: 17962954
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 LITER KRASNOVO KURSANTA STREET ST. PETERSBURG 1Z 197110
Business Address 25 LITER KRASNOVO KURSANTA STREET ST. PETERSBURG 1Z 197110 78002009911
PJSC Pharmsynthez (Filed by) CIK: 0001711454 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 1Z | Fiscal Year End: 1231
Type: SC 13D